Marshall Wace
ENZ

Marshall Wace’s Enzo Biochem, Inc. ENZ Stock Holding History

Marshall Wace’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-28,909
Closed -$92K – 3511
2021
Q2 		$92K Buy
+28,909
New +$90.9K ﹤0.01% 2540
2019
Q4 		– Sell
-12,465
Closed -$45K – 2141
2019
Q3 		$45K Sell
12,465
-12,306
-50% -$43.6K ﹤0.01% 1512
2019
Q2 		$83K Buy
+24,771
New +$87.3K ﹤0.01% 1277
2018
Q4 		– Sell
-111,945
Closed -$461K – 1854
2018
Q3 		$461K Buy
+111,945
New +$509K ﹤0.01% 946

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace's ENZ Position: Q3 2021 in Review

Marshall Wace sold out of Enzo Biochem, Inc. (ENZ) in Q3 2021, closing a stake of 28,909 shares — an estimated $92K sold.

Marshall Wace first reported a position in ENZ in Q3 2018 and held it in 4 quarters. The position peaked at $461K in Q3 2018. 65 funds tracked by Wall St. Rank hold ENZ as of Q3 2021.

  • Marshall Wace reported no remaining Enzo Biochem, Inc. position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace sold 28,909 Enzo Biochem, Inc. shares in Q3 2021, an estimated $92K.
  • Marshall Wace first reported a position in Enzo Biochem, Inc. in Q3 2018 and held it in 4 quarters.
  • Marshall Wace's Enzo Biochem, Inc. position peaked at $461K in Q3 2018.
  • 65 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2021.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.